| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Deliargyris Efthymios is a Chief Medical Officer at Cytosorbents Corp. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $207K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 13, 2023 | CTSO Cytosorbents Corp | Chief Medical Officer | Buy | 22,557 | $1.33 | $30,000.81 | +6.9% | -42.9% | -49.1% |